Ipsen has ‘firepower’ for more deals with €2B war chestnews2026-07-30T14:16:49+00:00July 30th, 2026|Endpoints News|
Gerresheimer divests two businesses worth €1.5B; Resilience, Lilly boost injectable pen capacitynews2026-07-30T13:30:04+00:00July 30th, 2026|Endpoints News|
Alnylam cuts Amvuttra sales guidance as demand shifts, hurting stocknews2026-07-30T13:25:38+00:00July 30th, 2026|Endpoints News|
Relation promises ‘transformationally different success rates’ in expanded AI pact with GSKnews2026-07-30T11:12:42+00:00July 30th, 2026|Endpoints News|
Sanofi records €1B+ write-off, ends work on two immunology assetsnews2026-07-30T09:35:05+00:00July 30th, 2026|Endpoints News|
J&J lines up $2.58B option to buy Sail, Flagship’s in vivo CAR-T biotechnews2026-07-30T04:32:19+00:00July 30th, 2026|Endpoints News|
FTC sues Hims for sharing sensitive health information, billing practicesnews2026-07-29T19:48:29+00:00July 29th, 2026|Endpoints News|
US releases $600M in funding for global health group Gavinews2026-07-29T19:14:46+00:00July 29th, 2026|Endpoints News|
Updated: FDA adcomm votes down Capricor’s DMD therapy over efficacynews2026-07-29T18:11:22+00:00July 29th, 2026|Endpoints News|
Teva is confident it has time to brace for tariffs on non-US genericsnews2026-07-29T17:27:21+00:00July 29th, 2026|Endpoints News|